Abstract
Infantile myofibromatosis (IM) is most commonly limited to cutaneous lesions that resolve spontaneously. However, generalized IM with visceral involvement, which has a reported mortality rate as high as 73%, has been successfully treated with a combination of methotrexate and vinblastine. Here we report the further efficacy of low-dose methotrexate and vinblastine in 2 pediatric patients with IM and visceral involvement and review the literature describing chemotherapy for these patients.
Original language | English (US) |
---|---|
Pages (from-to) | 402-405 |
Number of pages | 4 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 37 |
Issue number | 5 |
DOIs | |
State | Published - Jul 11 2015 |
Keywords
- infantile myofibromatosis
- methotrexate
- pediatrics
- vinblastine
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology